Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total knee arthroplasty: randomized controlled trial
Not Applicable
- Conditions
- Osteoarthritis of the knee Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000026137
- Lead Sponsor
- Hokusuikai Kinen Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 77
Inclusion Criteria
Not provided
Exclusion Criteria
Known allergic reaction to tranexamic acid Patients with preoperative hemoglobin level < 11.0 g/dL Refusal of blood products Enrollment in another interventional clinical trial within 6 months prior to surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The volume of perioperative blood loss measured using the calculated blood volume and change in hemoglobin from preoperative to postoperative day 3
- Secondary Outcome Measures
Name Time Method